1887

Chapter 5.16 : Selecting Antimicrobial Agents for Testing and Reporting

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Selecting Antimicrobial Agents for Testing and Reporting, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817435/9781555815271_Chap5_16-1.gif /docserver/preview/fulltext/10.1128/9781555817435/9781555815271_Chap5_16-2.gif

Abstract:

Developing protocols for antimicrobial susceptibility testing and reporting is best done with input from the infectious disease service, infection control, and the pharmacy and therapeutics committee. The goals are to provide clinically relevant information that will support cost-effective utilization of antimicrobial agents and to avoid reporting results that may adversely affect patient care. Because of differences in hospital formularies and laboratory functions, it is impossible to make specific recommendations and the suggestions described herein can only serve as a guide to the decision making processes. A list of commonly used antibacterial agents is shown in Appendix 5.16-1 .

Citation: Garcia L. 2010. Selecting Antimicrobial Agents for Testing and Reporting, p 220-228. In Clinical Microbiology Procedures Handbook, 3rd Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817435.ch5.16
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555817435.chap5.16
1. Abramowicz, M. (ed). 2001. The choice of antibacterial drugs. Med. Lett. 43:6978.
2. Gilbert, D. N.,, R. C. Moellering, Jr.,, and M. A. Sande. 2003. The Sanford Guide to Antimicrobial Chemotherapy, 33rd ed. Antimicrobial Therapy, Inc., Hyde Park, Vt.
3.NCCLS. 2003. Performance Standards for Antimicrobial Disk Susceptibility Tests, 8th ed. Approved standard M2-A8. NCCLS, Wayne, Pa.
4.NCCLS. 2003. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 6th ed. Approved standard M7-A6. NCCLS, Wayne, Pa.

Tables

Generic image for table
Untitled

Reference chart for commonly used antimicrobial agents

i.m., intramuscularly; p.o., orally; i.v., intravenously; VRE, vancomycin-resistant enterococci; MRSA, methicillin-resistant

Denotes the product name(s) according to or according to the manufacturer.

Investigational agent; not Food and Drug Administration approved as of January 2003.

Cephems have no activity against methicillin-resistant staphylococci, enterococci, or spp.

Active against

These agents are cephems but cephalosporins.

Citation: Garcia L. 2010. Selecting Antimicrobial Agents for Testing and Reporting, p 220-228. In Clinical Microbiology Procedures Handbook, 3rd Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817435.ch5.16
Generic image for table
Untitled

Reference chart for commonly used antimicrobial agents

i.m., intramuscularly; p.o., orally; i.v., intravenously; VRE, vancomycin-resistant enterococci; MRSA, methicillin-resistant

Denotes the product name(s) according to or according to the manufacturer.

Investigational agent; not Food and Drug Administration approved as of January 2003.

Cephems have no activity against methicillin-resistant staphylococci, enterococci, or spp.

Active against

These agents are cephems but cephalosporins.

Citation: Garcia L. 2010. Selecting Antimicrobial Agents for Testing and Reporting, p 220-228. In Clinical Microbiology Procedures Handbook, 3rd Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817435.ch5.16
Generic image for table
Untitled

Reference chart for commonly used antimicrobial agents

i.m., intramuscularly; p.o., orally; i.v., intravenously; VRE, vancomycin-resistant enterococci; MRSA, methicillin-resistant

Denotes the product name(s) according to or according to the manufacturer.

Investigational agent; not Food and Drug Administration approved as of January 2003.

Cephems have no activity against methicillin-resistant staphylococci, enterococci, or spp.

Active against

These agents are cephems but cephalosporins.

Citation: Garcia L. 2010. Selecting Antimicrobial Agents for Testing and Reporting, p 220-228. In Clinical Microbiology Procedures Handbook, 3rd Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817435.ch5.16
Generic image for table
Untitled

Reference chart for commonly used antimicrobial agents

i.m., intramuscularly; p.o., orally; i.v., intravenously; VRE, vancomycin-resistant enterococci; MRSA, methicillin-resistant

Denotes the product name(s) according to or according to the manufacturer.

Investigational agent; not Food and Drug Administration approved as of January 2003.

Cephems have no activity against methicillin-resistant staphylococci, enterococci, or spp.

Active against

These agents are cephems but cephalosporins.

Citation: Garcia L. 2010. Selecting Antimicrobial Agents for Testing and Reporting, p 220-228. In Clinical Microbiology Procedures Handbook, 3rd Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817435.ch5.16
Generic image for table
Untitled

Reference chart for commonly used antimicrobial agents

i.m., intramuscularly; p.o., orally; i.v., intravenously; VRE, vancomycin-resistant enterococci; MRSA, methicillin-resistant

Denotes the product name(s) according to or according to the manufacturer.

Investigational agent; not Food and Drug Administration approved as of January 2003.

Cephems have no activity against methicillin-resistant staphylococci, enterococci, or spp.

Active against

These agents are cephems but cephalosporins.

Citation: Garcia L. 2010. Selecting Antimicrobial Agents for Testing and Reporting, p 220-228. In Clinical Microbiology Procedures Handbook, 3rd Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817435.ch5.16
Generic image for table
Untitled

Reference chart for commonly used antimicrobial agents

i.m., intramuscularly; p.o., orally; i.v., intravenously; VRE, vancomycin-resistant enterococci; MRSA, methicillin-resistant

Denotes the product name(s) according to or according to the manufacturer.

Investigational agent; not Food and Drug Administration approved as of January 2003.

Cephems have no activity against methicillin-resistant staphylococci, enterococci, or spp.

Active against

These agents are cephems but cephalosporins.

Citation: Garcia L. 2010. Selecting Antimicrobial Agents for Testing and Reporting, p 220-228. In Clinical Microbiology Procedures Handbook, 3rd Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817435.ch5.16
Generic image for table
Untitled

Reference chart for commonly used antimicrobial agents

i.m., intramuscularly; p.o., orally; i.v., intravenously; VRE, vancomycin-resistant enterococci; MRSA, methicillin-resistant

Denotes the product name(s) according to or according to the manufacturer.

Investigational agent; not Food and Drug Administration approved as of January 2003.

Cephems have no activity against methicillin-resistant staphylococci, enterococci, or spp.

Active against

These agents are cephems but cephalosporins.

Citation: Garcia L. 2010. Selecting Antimicrobial Agents for Testing and Reporting, p 220-228. In Clinical Microbiology Procedures Handbook, 3rd Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817435.ch5.16

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error